Skip Navigation


Governor Kelly Announces More than $8M to be Invested in Digital Opportunities Governor Laura Kelly announced today that Kansas is receiving $8.2 million to begin implementing the Kansas Digital Equity (DE) Plan, which recently received federal approval. This announcement solidifies the state’s commitment to transform the landscape of high-speed internet connectivity and digital opportunity across Kansas. Nominations Open for 2024 Minority, Women Enterprise Development Awards Today Lieutenant Governor and Department of Commerce Secretary David Toland announced a call for nominations for the 2024 Minority Enterprise Development (MED) Week Awards. These annual awards are one way the agency acknowledges and observes the growing impact that minority- and women-led companies have on their communities and the Kansas economy. Governor Kelly Announces KMW to Invest $105M in Sterling, Create 251 New Jobs in Kansas Governor Laura Kelly today announced that KMW, a precision manufacturer of agricultural front loaders, backhoes, and other attachments, will invest $105 million to construct a new North American headquarters and state-of-the-art production facility in Sterling. The venture will create 251 new jobs, resulting in a local workforce of 485. Commerce Celebrates National Community Development Week The Kansas Department of Commerce is joining other organizations and communities across the state in commemorating National Community Development Week. The annual event, which this year is April 1-5, shines a spotlight on the transformative impact of community development initiatives and collaborative efforts that drive positive local change.  View All


Business Regions Made in Kansas Our Department Publications Initiatives & Incentives Transparency Database About Us Notices Contact

Webinar: China’s OTC Drug Market – Growth Potentials | Virtual | June 15, 2022

May 03, 2022

Share this post:

China’s Over-the-Counter (OTC) drug market, valued $19 billion, with 6% annual growth rate is expected to reach $26 billion by 2026. It accounts for one third of the total Asia-Pacific OTC market and keeps growing driven by the rising income of China’s huge population and the increasing trend in self-managed care.

Popular OTC drugs in China include traditional Chinese medicines, cough and cold medicines, vitamins and minerals, indigestion medicines, analgesics, medicated skincare products, topical medicines, band-aid and other first aid supplies, and similar products.

The National Medical Products Administration’s (NMPA) new drug registration regulation has streamlined the OTC drug registration procedures and process. It has shortened the time to bring OTC drugs to the market and enhanced market opportunities for U.S. OTC drugs, which are well-regarded by Chinese consumers for their safety, quality, and efficacy.

This webinar will provide an overview of China’s OTC drug market, market opportunities, market access requirements, IP considerations, and best practices. We will also introduce cross-border e-Commerce channels for selling OTC drugs. 

Make sure your questions get answered ahead of time!  Please email [email protected] with topics you would like discussed or questions you would like answered during the webinar.

  • Date: June 15, 2022 
  • Time: 
    • June 15, 4:00 – 5:10 pm (Pacific Time)
    • June 15, 8:00 – 9:10 pm (Eastern Time)
    • June 16, 8:00 – 9:10 am (Beijing Time) 
  • Registration Deadline: June 15, 2022
  • Where: Virtual 
  • Cost:$25

For more information please contact: [email protected]